Status:
RECRUITING
Provider Recommendation and HPV Vaccination
Lead Sponsor:
Kaiser Permanente
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Human Papillomavirus
Eligibility:
All Genders
21-70 years
Phase:
NA
Brief Summary
In the United State, there are millions of US teens who are not vaccinated against the human papillomavirus (HPV) putting them at risk of getting HPV-related cancers. Although there are clinical guide...
Detailed Description
US teens remain at risk of developing human papillomavirus (HPV)-related cancers due to inadequate HPV vaccine uptake, despite strong endorsement in clinical guidelines and substantial intervention ef...
Eligibility Criteria
Inclusion
- All KPSC pediatric clinics.
- All providers (physicians, nurses, and medical assistants) and department administrators from the pediatric department.
- Parents of HPV vaccine-eligible children (9-12 years old).
Exclusion
- Providers and administrators who do not work for the pediatric department
- Parents of children older than 12 years and/or who did not have a clinic visit in the study period.
Key Trial Info
Start Date :
March 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
301201 Patients enrolled
Trial Details
Trial ID
NCT05365048
Start Date
March 21 2022
End Date
June 30 2026
Last Update
May 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Southern California
Pasadena, California, United States, 91101